Long‐term lansoprazole control of gastric acid and pepsin secretion in ZE and non‐ZE hypersecretors: a prospective 10‐year study

Background: The majority of patients with Zollinger–Ellison syndrome require lifelong treatment with proton pump inhibitors. Aims: To determine the efficacy of lansoprazole control of acid and pepsin secretion over the long term in Zollinger–Ellison syndrome and non‐Zollinger–Ellison syndrome hypers...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Alimentary pharmacology & therapeutics 2001-11, Vol.15 (11), p.1795-1806
Hauptverfasser:	Hirschowitz, B. I., Simmons, J., Mohnen, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	2-Pyridinylmethylsulfinylbenzimidazoles Adult Biological and medical sciences Digestive system Dose-Response Relationship, Drug Drug Administration Schedule Enzyme Inhibitors - administration & dosage Enzyme Inhibitors - pharmacology Female Follow-Up Studies Gastric Acid - metabolism Gastric Acidity Determination Humans Lansoprazole Male Medical sciences Middle Aged Omeprazole - administration & dosage Omeprazole - analogs & derivatives Omeprazole - pharmacology Pepsin A - drug effects Pepsin A - metabolism Pharmacology. Drug treatments Prospective Studies Proton Pump Inhibitors Treatment Outcome Zollinger-Ellison Syndrome - complications Zollinger-Ellison Syndrome - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!